Skip to content

The Effect of Cocoa on Platelet Function Profiles in Patients

The Effect of Cocoa on Platelet Function Profiles in Patients With Stable Coronary Artery Disease in Trinidad and Tobago: The ECLAIR Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04554901
Acronym
ECLAIR
Enrollment
25
Registered
2020-09-18
Start date
2020-09-01
Completion date
2022-06-30
Last updated
2023-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Platelet Dysfunction

Keywords

Platelet Dysfunction, Cocoa, Polyphenol

Brief summary

The effects of chocolate on cardiovascular health are still a matter of debate. It can potentially favor cardiovascular health through the antioxidative effects of cocoa ingredients, such as polyphenols (present in dark but not white chocolate).

Detailed description

Epidemiologic studies have shown inverse associations between dietary polyphenols (present in dark chocolate and cocoa) and mortality from coronary heart disease. However, the basis for this protective association is uncertain. Food polyphenols such as in cocoa reportedly have antioxidant properties and decrease platelet function in vitro. The goal of the present study was to investigate whether the beneficial antioxidant effect of polyphenol-rich cocoa can induce an improvement of endothelial and platelet function in patients with stable coronary artery disease with known platelet hyperreactivity.

Interventions

DIETARY_SUPPLEMENTCocoa

2-week, once-daily 70%, 50g cocoa bar manufactured by The UWI Cocoa Research Institute (14 bars)

Sponsors

The University of The West Indies
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Blood samples will be collected from participants in 2 separate instances. Initially, a baseline VerifyNow P2Y12 PRU test assay, followed by a subsequent repeat test 2-week after a 2-week, once-daily 70%, 50g cocoa bar manufactured by The UWI Cocoa Research Institute (14 bars).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Patients with stable coronary artery disease. 2. Patients \> 18y of age.

Exclusion criteria

1. Patients with T2DM. 2. Patients who already ingest any cocoa-based products.

Design outcomes

Primary

MeasureTime frameDescription
P2Y12 Reaction Units2-weeksP2Y12 Reaction Units pre- and post-Cocoa

Countries

Trinidad and Tobago

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026